New Zealand markets closed

Boston Scientific Corporation (BSX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
74.92+0.66 (+0.89%)
At close: 04:00PM EDT
75.00 +0.08 (+0.11%)
After hours: 07:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 110.15B
Enterprise value 118.82B
Trailing P/E 60.91
Forward P/E 32.05
PEG ratio (5-yr expected) 2.15
Price/sales (ttm)7.28
Price/book (mrq)5.53
Enterprise value/revenue 7.80
Enterprise value/EBITDA 36.42

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 344.49%
S&P500 52-week change 318.96%
52-week high 379.43
52-week low 348.35
50-day moving average 376.40
200-day moving average 365.22

Share statistics

Avg vol (3-month) 35.92M
Avg vol (10-day) 38.11M
Shares outstanding 51.47B
Implied shares outstanding 61.47B
Float 81.47B
% held by insiders 10.19%
% held by institutions 192.70%
Shares short (15 Jul 2024) 411.53M
Short ratio (15 Jul 2024) 42.12
Short % of float (15 Jul 2024) 40.79%
Short % of shares outstanding (15 Jul 2024) 40.78%
Shares short (prior month 14 Jun 2024) 411.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 306 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 12.00%
Operating margin (ttm)20.39%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)15.23B
Revenue per share (ttm)10.38
Quarterly revenue growth (yoy)14.50%
Gross profit (ttm)N/A
EBITDA 3.96B
Net income avi to common (ttm)1.83B
Diluted EPS (ttm)1.23
Quarterly earnings growth (yoy)20.00%

Balance sheet

Total cash (mrq)2.33B
Total cash per share (mrq)1.58
Total debt (mrq)11B
Total debt/equity (mrq)54.55%
Current ratio (mrq)N/A
Book value per share (mrq)13.56

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A